Home > Healthcare > Medical Devices > Therapeutic Devices > Dermal Filler Market
Dermal Filler Market Size
Dermal Filler Market size accounted for USD 5.5 billion in 2022 and is estimated to grow at 10.5% to reach USD 14.8 billion by 2032. The demand for cosmetic surgeries for facial rejuvenation and anti-aging treatment is increasing due to the ageing population.
For instance, according to WHO estimates, by 2030, one in every six people in the world will be 60 or older. As per statistics, the geriatric population size will get double from 1 billion in 2020 to 2.1 billion in 2050. Dermal fillers benefit the elderly individual’s aesthetics by repairing lost volume and uplifting sagging skin. Additionally, rising medical tourism to nations such as India and Thailand for cosmetic operations and increasing healthcare spending on aesthetic procedures will support market growth in the forthcoming year.
Dermal fillers, also known as injectable implants, wrinkle fillers, lip and facial fillers, or soft tissue fillers are used to enhance the appearance of the face and facial features. Dermal filler materials are designed to be injected into the skin to add volume and fullness. These fillers are approved to produce a smoother and fuller appearance on the face, including nasolabial folds, chin, lips.
Report Attributes | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022: | USD 5.5 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 10.5% |
2032 Value Projection: | USD 14.8 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 242 |
Tables, Charts & Figures: | 326 |
Segments covered: | Product Type, Material Type, Application, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
COVID-19 Impact
The COVID-19 pandemic had a negative impact on the cosmetic dermatology and aesthetic medicine sector as it faced challenges in manufacturing and supply chain disruptions globally. Lockdown measures, travel restrictions, and reduced workforce caused delays in production, transportation, and distribution of dermal fillers, leaded to shortages and limited availability in various regions.
Additionally, elective medical procedures, including aesthetic treatments, were heavily restricted during the peak of the pandemic, resulted in temporary closures of non-essential clinics and a significant declined in demand for cosmetic procedures. Despite these obstacles, companies implemented strategic measures to sustain their operations, such as adopting telehealth for online consultations and education, and leveraging e-commerce channels for product supply and marketing.
Dermal Filler Market Trends
The demand for facial aesthetics continues to experience development. There has been a notable ongoing increase in the number of facial aesthetic procedures, such as injectables and dermal fillers on a global scale. This continuous gains can be attributed to ongoing technological advancements, persistent improvements in safety profiles, and the enduring desire for enhanced facial features.
Furthermore, women constitute a significant portion of the population seeking facial aesthetic treatments. The increasing focus on physical appearance and the desire to maintain a youthful look contribute to the growing demand for facial aesthetics among women. Moreover, increasing general awareness and consciousness regarding physical appearance, primarily driven by the continuous influence of media, social platforms, and the unchanging desire to project a positive self-image will supplement the market revenue.
Dermal Filler Market Restrain
A growing concern among people regarding side effects associated with the use of dermal fillers will restrict the market evolution to some extent. Permanent dermal fillers are made up of materials that the human body is unable to reabsorb and break down. Thus, the body is likely to ward itself off, leading to complications such as infections and biofilm formation. In addition, permanent fillers are non-removable and cause irreversible damage to human body. On the other hand, normally witnessed complications of absorbable and non- absorbable dermal filler include redness, pain, swelling, and ecchymosis.
Dermal Filler Market Analysis
By product type, the dermal filler market is classified into absorbable and non-absorbable. The absorbable segment accounted for 94.7% of the market share in 2022. Absorbable materials refer to substances that can be naturally broken down and absorbed by the body over time. Unlike permanent materials or implants, absorbable materials are designed to be temporary and gradually degrade within the body. This feature provides consumers with the flexibility to experiment with their appearance and make changes without committing to permanent alterations.
Based on material type, the dermal filler market is segmented into hyaluronic acid (HA), calcium hydroxylapatite, poly-L-lactic acid, polymethyl-methacrylate microspheres (PMMA), collagen, fat fillers, and other material types. The material type segment is further divided based on their application. The hyaluronic acid (HA) is expected to register around USD 8.6 billion by 2032. Hyaluronic acid (HA) dermal fillers offer several advantages. HA is a biocompatible substance that is naturally present in the body thus, minimizing the risk of adverse reactions and allergic responses. Furthermore, the ability of HA fillers to target different areas and concerns makes them a popular choice among both patients and cosmetic professionals.
The hyaluronic acid (HA) is further categorized based on its application including face lift, facial corrections, wrinkles reduction, breast enhancement, acne scar treatment, lip enhancement, and others application. The face lift segment in hyaluronic acid (HA) accounted for 10.1% of the market share in 2022. The versatility of HA fillers in various treatment areas and their compatibility with other aesthetic procedures will further contribute to market expansion.
By application, the dermal filler market is segmented into face lift, facial corrections, wrinkles reduction, acne scar, lipoatrophy, lip enhancement, hip augmentation, breast enhancement, hand rejuvenation, penis enlargement, blepharoplasty, neck & chin lift, and other applications. The lip enhancement segment is expected to grow at a considerable CAGR of 11.1% during the forecast period. The rising demand for fuller and more defined lips among individuals seeking to enhance their facial aesthetics will fuel the progress of this segment.
Additionally, advancements in dermal filler technology and techniques have enabled healthcare professionals to deliver precise and customized lip enhancements, thereby propelling market development. Moreover, the non-invasive nature of lip enhancement procedures using dermal fillers appeals to a broader consumer base, offering convenient and efficient solutions without the need for surgical interventions.
The end-use in dermal filler market is divided into hospitals, dermatology clinics, and other end-users. Dermatology clinics accounted for USD 3.1 billion market revenue in 2022. The presence of qualified plastic surgeons worldwide, an increase in the number of clinics offering specialised services, and rising healthcare infrastructure will all have a positive impact on the segment’s growth in the forthcoming years. Furthermore, increasing acceptance of anti-aging treatment among the women in developed countries along with expanding healthcare facilities is anticipated to witness increased patient inflow in dermatological clinics. These clinics offer personalized and customized cosmetic treatments.
North America dermal filler market accounted for 35.7% business share in 2022.The regional growth is primarily attributable to the growing adoption of several facial procedures including injectables for better facial appearance. The region has witnessed a significant trend shift from invasive to non-invasive treatments.
For instance, according to the report published by the American Society of Plastic Surgeons (ASPS), in 2020, more than 15.5 million minimally invasive and surgical aesthetic procedures were conducted in the U.S. Adding to this, increasing product availability with rising number of product approvals by the U.S. FDA will expand product accessibility which will further contribute to regional value.
Dermal Filler Market Share
Major market players operating in the dermal filler market include
- AbbVie (Allergan plc)
- Galderma
- Sinclair Pharma Limited (Huadong Medicine Co., Ltd)
- Merz Aesthetics
Dermal Filler Industry News:
- In August 2022, AbbVie Inc. received U.S. FDA approval for its JUVÉDERM VOLUX XC. It is used to improve jawline definition in adults. This helped the company to broaden its portfolio and maintain its market position.
- In February 2021, Sinclair Pharma launched Lanluma, a novel bio-stimulating Poly-L-lactic acid aesthetic fillers for cosmetic procedures. This strategy helped the company to expand its product portfolio and customer base.
The dermal filler market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By product type
- Absorbable
- Non-absorbable
Material type
- Hyaluronic acid (HA)
- Face lift
- Facial corrections
- Wrinkles reduction
- Breast enhancement
- Acne scar treatment
- Lip enhancement
- Other applications
- Calcium hydroxylapatite
- Facial corrections
- Wrinkles reduction
- Acne scar treatment
- Other applications
- Poly-L-lactic acid
- Facial corrections
- Wrinkles reduction
- Breast enhancement
- Acne scar treatment
- Other applications
- Polymethyl-methacrylate microspheres (PMMA)
- Facial corrections
- Wrinkles Reduction
- Acne scar treatment
- Collagen
- Face lift
- Facial corrections
- Wrinkles Reduction
- Breast enhancement
- Acne scar treatment
- Other applications
- Fat fillers
- Face lift
- Facial corrections
- Wrinkles Reduction
- Breast enhancement
- Acne scar treatment
- Other applications
- Other material types
- Wrinkles Reduction
- Hand rejuvenation
- Acne scar
Application
- Face lift
- Facial corrections
- Wrinkles reduction
- Acne scar
- Lipoatrophy
- Lip enhancement
- Hip augmentation
- Breast enhancement
- Hand rejuvenation
- Penis enlargement
- Blepharoplasty
- Neck & chin lift
- Other applications
End-use
- Hospitals
- Dermatology clinics
- Other end-users
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
Frequently Asked Questions (FAQ) :